VIR News and Press, Vir Biotechnology Inc. From 03/30/22

Gainers: Adagio Therapeutics (ADGI) +47%. Insignia Systems (ISIG) +26%. Romeo Power (RMO) +24%. Vir Biotechnology (VIR) +20%. TMC the metals company (TMC) +19%. Arhaus (ARHS) +19%. Ambac Financial Group (AMBC) +18%. Pear Therapeutics (PEAR) +17%. Vyant Bio (VYNT) +16%. Sportradar (SRAD) +16%....

Retailers from both sides of the price spectrum raised caution flags on Wednesday, with RH (NYSE:RH) and Five Below (FIVE) each losing ground in midday trading on earnings news. Meanwhile, MillerKnoll (MLKN) saw strength in the wake of its quarterly update. Solid results and an upbeat forecas...

Gainers: Adagio Therapeutics (ADGI) +48%. Vyant Bio (VYNT) +23%. Vir Biotechnology (VIR) +19%. Sonoma Pharmaceuticals (SNOA) +15%. Syros Pharmaceuticals (SYRS) +15%. Losers: Revelation Biosciences (REVB) -40%. UpHealth (UPH) -29%. The Valens (VLNS)...

Adagio Therapeutics (ADGI) +64% as COVID drug ADG20 meets main goals in trial; EUA filing in Q2. Vyant Bio (VYNT) +29% on FY results. Sonoma Pharmaceuticals (SNOA) +24% launches new urinary tract infection product through distributors in New Zealand, Australia and Sou...

Investors have been impressed at the rapid pace at which the stock market has clawed back its losses from early in 2022. The Nasdaq Composite (NASDAQINDEX: ^IXIC) in particular has rebounded sharply, and so it made sense for the index to take a brief break from its ascent early Wedn...

Camden Property Trust Set to Join S&P 500; Matador Resources to Join S&P MidCap 400; Vir Biotechnology to Join S&P SmallCap 600 Camden Property Trust Set to Join S&P 500; Matador Resources to Join S&P MidCap 400; Vir Biotechnology to Join S&P SmallCap 600...

Several data readouts of HB-200 alone and in combination with KEYTRUDA for treatment of HPV16+ HNSCC patients are expected in 2022. An amended agreement with Gilead Sciences, for arenavirus platform to develop treatments for HIV and HBV, established $54 million in commitment cash. ...

A late-day surge allowed the major U.S. equity averages to end an otherwise lackluster trading session with respectable gains. A drop in oil prices helped give stocks a boost. Amid the overall advance, cryptocurrency stocks performed extremely well. A general rally in the crypto complex suppo...

Clever Leaves Holdings (CLVR) -20% after sharp rally last week. Companhia Energetica (CIG) -15%. BiondVax Pharmaceuticals (BVXV) -9% on FY earnings release. Enservco (ENSV) -8% announces to amend its Financial Statements for First, Second and Third Quarters of 2021. Indone...

SAN FRANCISCO, March 25, 2022 (GLOBE NEWSWIRE) -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the US Food and Drug Administration has amended the Emergency Use Authorization (EUA) Fact Sheet for sotrovimab, an investigational monoclonal...